Tuberculosis Tag

  • All
  • Advocacy Hub
  • Advocacy Update
  • Blog Posts
  • GHC Announcements
  • News Center
  • Statement
Overcoming Challenges in the Introduction and Scale-Up of Newer Drugs for the Treatment of Multi-Drug Resistant Tuberculosis: Lessons from the Field

Organized by  DR-TB STAT

Symposium at the 2017 Union World Conference on Lung Health
October 12
10:30 AM – 12:00 PM
Hall 9, Jalisco Hall
Guadalajara, Mexico

MORE INFORMATION AND REGISTRATION FOR 2017 UNION WORLD CONFERENCE ON LUNG HEALTH
(Conference registration is required to attend the symposium. Register online by October 10. On-site registration available after October 10)

2
MSF at the 48th Union World Conference On Lung Health

Organized by

 

More MSF Events

EndTB Symposium: Accelerating TB Elimination Through Access to Bedaquiline and Delamanid
October 12
2:00 PM – 3:30 PM
Hall 10, Jalisco Hall
Guadalajara, Mexico

The symposium will provide an update on the UNITAID-funded endTB initiative and findings, including culture conversion and reversion and adverse events for the 600 people who have received bedaquiline or delamanid.

Community space (Encuentro) session: Five urgent improvements to DR-TB treatment
October 13
5:00 PM – 6:00 PM
Foro – Encuentro Expo
Guadalajara, Mexico

Evidence for treatment with newer DR-TB drugs, shorter treatment regimens, ambulatory care instead of hospitisation, and fast-track registration of new drugs.

MSF Symposium: Reducing Catastrophic Costs for People with TB through Patient-Centred care
October 14
10:30 AM – 12:00 PM
Hall 10, Jalisco Hall

Session will analyse the barriers to reducing costs and burden for people with drug-resistant TB including: decentralised and ambulatory treater, shorter treatment and newer drugs to reduce toxicity, and interventions to reduce out-of-pocket costs of treatment.


2
Tuberculosis along the lifecycle: opportunities for integration of TB, HIV and maternal health programmes

Organized by
U.S. Centers for Disease Control and Prevention (CDC), The United Nations Children’s Fund (UNICEF), and Child Survival Working Group

October 5
8:30 AM – 9:30 AM EDT
JOIN THE WEBINAR (SKYPE)
(To join by phone, see details below)

For any questions, please contact jerodrigues@unicef.org.



The webinar will be moderated by Anne Detjen, UNICEF, Surbhi Modi, CDC and Jessica Rodrigues, UNICEF.

Presentations include:

1) TB in women, infants, children and adolescents – key data, gaps and opportunities
Steve Graham, University of Melbourne and The International Union Against TB and Lung Disease
2) Addressing TB along the lifecycle – lessons from Uganda
Moorine Sekadde, National TB Programme, Uganda
3) Kenya’s experience providing IPT in PMTCT settings 
Immaculate Kathure, National TB Programme, Kenya

Join by phone:

Use Conference ID: 57813351

United States : +16467571480 (Global) English (United States)
Switzerland : +41225083200 (Global) English (United States)
Hungary : +3617909400 (Global) English (United States)
United Kingdom : +443300102423 (Global) English (United Kingdom)
Jordan : +96265509679 (Global) Arabic (Saudi Arabia)
Panama : +5073017399 (Global) English (United States)
Cambodia : +85523260206 (Global) English (United Kingdom)
South Africa : +27879403508 (Global) English (United Kingdom)
Bulgaria : +35924928220 (Global) English (United Kingdom)
Denmark : +4578793993 (Global) English (United States)
France : +33176542732 (Global) French (France)
Netherlands : +31705680050 (Global) English (United States)
Australia : +61730628687 (Global) English (Australia)
Brazil : +556136860910 (Global) Portuguese (Brazil)
Belgium : +3228087101 (Global) French (France)
Greece : +302112340299 (Global) English (United Kingdom)
Italy : +390697632494 (Global) Italian (Italy)
Find a local number

 

2
Expanding Use of TB LAM Test for People with HIV

Organized by Treatment Action Group (TAG)

October 3
8:30 AM – 10:00 AM EDT
Webinar

REGISTRATION

Tuberculosis (TB) is the leading killer of people living with HIV, making the TB LAM test critically important to saving the lives of people living with HIV. LAM is the only point-of-care TB diagnostic test, and is specifically used for detecting TB in people with HIV with low CD4 counts. The LAM test is the only test that has a proven impact on reducing TB deaths in people with HIV.

Join TAG and global partners for a webinar on urging policymakers and funders to procure and implement the TB LAM test.

Speakers include:

1) Lynette Mabote AIDS & Rights Alliance for Southern Africa
2) Stephen Wanjala, Médecins Sans Frontières Wayne van Gemert,
3) Global Drug Facility

Moderator: Khairunisa Suleiman, Global TB CAB and Independent Consultant

 

3